Bar Plot from Scientific Research

Swimmer plot of evaluable patients and their clinical outcomes. WHO grade is at time of treatment. Tumor IDH mutations are indicated by yes (Y) or no (N); ND, not determined; DS, dose schedule. Black lines indicate CAR-T cell cycles administered to route dictated by arm (arm 1: ICT-Biopsy; arm 2: ICT-Resection; arm 3: ICV; arms 4 and 5: dual ICT/ICV). White lines indicate additional CAR-T cell cycles administered ICV. Yellow lines indicate additional CAR-T cell cycles administered ICT. Bold UPN numbers, evaluable rGBM patients ( n = 42, evaluable for survival n = 41); #, diffuse midline glioma, H3 K27-altered.

DOI